Authors:
Vandamme, AM
Houyez, F
Banhegyi, D
Clotet, B
De Schrijver, G
De Smet, KAL
Hall, WW
Harrigan, R
Hellmann, N
Hertogs, K
Holtzer, C
Larder, B
Pillay, D
Race, E
Schmit, JC
Schuurman, R
Shulse, E
Sonnerborg, A
Miller, V
Citation: Am. Vandamme et al., Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up, ANTIVIR TH, 6(1), 2001, pp. 21-39
Authors:
Miller, V
Vandamme, AM
Loveday, C
Staszewski, S
Lundgren, J
Youle, M
Ait-Khaled, M
Boucher, C
Brun-Vezinet, F
Dedes, N
Giaquinto, C
Hertogs, K
Houyez, F
Perrin, L
Pillay, D
Schmit, JC
Schuurman, R
Lange, J
Banhegyi, D
Biondi, G
Broekhuizen, A
Bush-Donovan, C
Camacho, R
Carlier, H
Clavel, F
Clotet, B
Clumeck, N
Colebunders, R
De Clerq, K
De Jaegher, JJ
De Schrijver, G
De Smet, K
Hall, W
Harrigan, R
Hatzakis, A
Hellmann, N
Hoetelmans, R
Holtzer, C
Katlama, C
Larder, D
Loriaux, E
McCreedy, B
Mulcahy, F
Opravil, M
Phillips, A
Ruiz, N
Shulse, E
Sonnerborg, A
Soriano, V
Steel, H
Vella, S
Williams, A
Citation: V. Miller et al., Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting, AIDS, 15(3), 2001, pp. 309-320
Authors:
Chaix-Couturier, C
Holtzer, C
Phillips, KA
Durand-Zaleski, I
Stansell, J
Citation: C. Chaix-couturier et al., HIV-1 drug resistance genotyping - A review of clinical and economic issues, PHARMACOECO, 18(5), 2000, pp. 425-433
Authors:
Jacobson, MA
Stanley, H
Holtzer, C
Margolis, TP
Cunningham, ET
Citation: Ma. Jacobson et al., Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy, CLIN INF D, 30(1), 2000, pp. 231-233
Authors:
Jacobson, MA
Wilson, S
Stanley, H
Holtzer, C
Cherrington, J
Safrin, S
Citation: Ma. Jacobson et al., Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS, CLIN INF D, 28(3), 1999, pp. 528-533